Immunome

Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19

EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced a recent update regarding its Investigational New Drug (IND) submission for IMM-BCP-01, a three-antibody cocktail, for the treatment of SARS-CoV-2 (COVID-19).

Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19 Read More
Ocugen

Vaccine Candidate from Chester County-based Biopharmaceutical Company Shown to Neutralize Omicron and Delta Variants

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) and its partner, Bharat Biotech announced resent results from a study conducted at Emory University demonstrating that sera from subjects who received a …

Vaccine Candidate from Chester County-based Biopharmaceutical Company Shown to Neutralize Omicron and Delta Variants Read More